List view / Grid view
8 January 2018 | By Dr Zara Kassam (Drug Target Review)
In a proof-of-principle case report, researchers announce that targeted fluorescence successfully identified pulmonary metastases in a patient with osteosarcoma...
2 November 2023 | By Drug Target Review
Percent necrosis calculated with machine learning model for patients with osteosarcoma provides an accurate prognosis for survival.
20 November 2023 | By Ellen Capon (Drug Target Review)
New imaging technology called fluorescence lifetime (FLT) imaging improves the accuracy of cancer surgery for multiple tumour types.
8 April 2019 | By Nic Losardo (Drug Target Review)
A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe and showed clinical responses in paediatric and adult patients with advanced HER2-positive sarcoma...
20 June 2015 | By Horst Flotow (Singapore Screening Centre)
Cancer cells are addicted to glucose and glutamine, which enables them to generate the energy and macromolecule synthesis intermediates to support their growth...
6 December 2019 | By Hannah Balfour (Drug Target Review)
Researchers have reprogrammed CAR T cells to prevent them becoming exhausted after prolonged activity, presenting a possible new therapy for solid tumours.
